In response to the current COVID-19 pandemic, the ANCHOR study team has advised local site staff to contact ANCHOR participants who are scheduled to be seen in the next 4 weeks about whether they should come in for their appointment. If you do not hear from your site’s study staff, please reach out to them. If you are waiting to be screened for the ANCHOR study, please be patient- we WILL see you as soon as we possibly can, once it is safe to do so. In the meantime, please contact your local ANCHOR site if you have any questions or concerns.
Ronald Mitsuyasu, M.D.
Dr. Mitsuyasu is the Group Chairman and PI for the AIDS Malignancy Consortium (AMC) and the PI for the UCLA AMC site. He is an ex officio and active member of all of the AMC WG and Committees. He is Professor of Medicine, Division of Hematology-Oncology at UCLA, Director of the UCLA Center for Clinical AIDS Research and Education (CARE Center) and the Associate Director for Clinical Therapeutics and Biomedical Prevention of the UCLA CFAR and AIDS Institute. He has served in leadership positions within both the ACTG and AMC having served as the PI of the UCLA ACTG from 1989 to 2004 and as former chairman of the ACTG Immunology Research Agenda Committee. He is a member of the NCI Board of Scientific Advisors Subcommittee on AIDS Malignancies, the Office of AIDS Research Advisory Council, and he has served on an FDA Advisory Committee, various scientific review boards and study sections and has been the PI of many clinical trials protocols over the past 30 years. He has been a clinical investigator in HIV-associated malignancies since 1982, when he founded the KS clinic at UCLA, and he has conducted trials with immune-based and gene therapy for HIV. The CARE Center’s primary function is to support and conduct clinical investigations in HIV Dr. Mitsuyasu's research interests include clinical investigations of immune-based, biological and genetic therapies for HIV and treatments of HIV-associated malignancies. At UCLA, he will be the administrative director and clinical investigator for the ANCHOR study.